|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2200 AUD | -12.00% |
|
-10.20% | +2.33% |
| 16/01 | Paragoncare Announces Changes to the Ramsay Healthcare Contract | CI |
| 16/01 | Paragon Care announces changes to Ramsay Healthcare contract | RE |
| Capitalization | 364M 243M 210M 195M 182M 338M 22.08B 2.25B 886M 10.53B 912M 894M 38.45B | P/E ratio 2026 * |
11.6x | P/E ratio 2027 * | 9.57x |
|---|---|---|---|---|---|
| Enterprise value | 555M 371M 319M 297M 277M 516M 33.63B 3.42B 1.35B 16.04B 1.39B 1.36B 58.57B | EV / Sales 2026 * |
0.15x | EV / Sales 2027 * | 0.14x |
| Free-Float |
25.62% | Yield 2026 * |
-
| Yield 2027 * | 5.91% |
Last Transcript: Paragon Care Limited
| 1 day | -12.00% | ||
| 1 week | -10.20% | ||
| Current month | +2.33% | ||
| 1 month | -15.38% | ||
| 3 months | -18.52% | ||
| 6 months | -42.86% | ||
| Current year | +2.33% |
| 1 week | 0.22 |  | 0.26 |
| 1 month | 0.2 | | 0.26 |
| Current year | 0.21 | | 0.26 |
| 1 year | 0.2 | | 0.59 |
| 3 years | 0.2 | | 0.59 |
| 5 years | 0.2 | | 0.59 |
| 10 years | 0.2 | | 0.59 |
| Manager | Title | Age | Since |
|---|---|---|---|
Carmen Riley
CEO | Chief Executive Officer | - | 01/07/2025 |
Brendon Pentland
DFI | Director of Finance/CFO | - | 08/12/2025 |
David Collins
CEO | Chief Executive Officer | - | 03/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
John Walstab
BRD | Director/Board Member | - | 16/02/2022 |
Carmen Riley
BRD | Director/Board Member | - | 03/06/2024 |
Peter Lacaze
CHM | Chairman | - | 03/06/2024 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -12.00% | -10.20% | -55.56% | - | 243M | |
| -1.43% | -3.30% | +7.30% | +7.38% | 212B | |
| -2.26% | -0.79% | +9.85% | +20.42% | 124B | |
| -0.14% | +5.71% | +46.60% | +116.16% | 68.84B | |
| -0.60% | +2.15% | -12.75% | -19.10% | 59.01B | |
| -1.11% | +1.34% | +23.42% | +93.84% | 54.23B | |
| +3.30% | +8.88% | - | - | 36.72B | |
| +0.43% | +3.18% | -17.59% | -36.50% | 27.12B | |
| +0.15% | +4.61% | +28.16% | +34.41% | 26.37B | |
| +0.38% | -0.47% | +8.27% | -33.36% | 24.07B | |
| Average | -1.33% | +1.11% | +4.19% | +22.91% | 63.24B | |
| Weighted average by Cap. | -0.86% | +0.50% | +11.66% | +25.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.68B 2.46B 2.12B 1.97B 1.84B 3.42B 223B 22.7B 8.95B 106B 9.22B 9.03B 389B | 3.88B 2.59B 2.24B 2.08B 1.94B 3.61B 235B 23.94B 9.44B 112B 9.72B 9.52B 410B |
| Net income | 31.6M 21.11M 18.2M 16.94M 15.77M 29.37M 1.92B 195M 76.85M 914M 79.18M 77.55M 3.34B | 37.65M 25.16M 21.69M 20.19M 18.79M 34.99M 2.28B 232M 91.57M 1.09B 94.34M 92.39M 3.98B |
| Net Debt | 190M 127M 110M 102M 95.1M 177M 11.55B 1.17B 463M 5.51B 477M 467M 20.11B | 181M 121M 104M 96.84M 90.15M 168M 10.95B 1.11B 439M 5.22B 453M 443M 19.07B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/01/26 | 0.2200 $ | -12.00% | 2,614,190 |
| 15/01/26 | 0.2500 $ | +2.04% | 288,718 |
| 14/01/26 | 0.2450 $ | -2.00% | 1,399,307 |
| 13/01/26 | 0.2500 $ | 0.00% | 103,693 |
| 12/01/26 | 0.2500 $ | +2.04% | 530,057 |
Delayed Quote Australian S.E., 16 January 2026 at 04:11 pm AEDT
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PGC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition